Marshall Wace North America’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,106
| Closed | -$601K | – | 1671 |
|
|
2021
Q2 | $601K | Sell |
10,106
-1,979
| -16% | -$118K | ﹤0.01% | 1082 |
|
|
2021
Q1 | $810K | Sell |
12,085
-6,023
| -33% | -$404K | ﹤0.01% | 1068 |
|
|
2020
Q4 | $1.1M | Sell |
18,108
-8,904
| -33% | -$539K | ﹤0.01% | 922 |
|
|
2020
Q3 | $2.13M | Buy |
27,012
+12,445
| +85% | +$983K | 0.01% | 566 |
|
|
2020
Q2 | $910K | Buy |
+14,567
| New | +$910K | 0.01% | 784 |
|
|
2020
Q1 | – | Sell |
-21,614
| Closed | -$2.62M | – | 1609 |
|
|
2019
Q4 | $2.62M | Buy |
+21,614
| New | +$2.62M | 0.01% | 523 |
|
|
2019
Q1 | – | Sell |
-276
| Closed | -$53K | – | 1909 |
|
|
2018
Q4 | $53K | Buy |
+276
| New | +$53K | ﹤0.01% | 1240 |
|